Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11076
CALL
KLX Energy Services
KLXE
$42.3M
| $181K | ﹤0.01% |
95,600
+69,500
| +266% | +$121K |
|
11077
PUT
Imperial Petroleum
IMPP
$208M
| $181K | ﹤0.01% |
49,900
+25,700
| +106% | +$126K |
|
|
RPT
11078
Rithm Property Trust
RPT
$93.7M
| $181K | ﹤0.01% |
10,887
-51,797
| -83% | -$796K |
|
11079
CALL
ProShares VIX Mid-Term Futures ETF
VIXM
$40.7M
| $180K | ﹤0.01% |
+11,800
| New | +$189K |
|
|
DENN
11080
DELISTED
Denny's
DENN
| $179K | ﹤0.01% |
28,837
-172,478
| -86% | -$978K |
|
11081
PUT
Treace Medical Concepts
TMCI
$309M
| $179K | ﹤0.01% |
+73,200
| New | +$318K |
|
11082
CALL
Comtech Telecommunications
CMTL
$51.8M
| $179K | ﹤0.01% |
+33,900
| New | +$111K |
|
11083
CALL
Limoneira
LMNR
$251M
| $179K | ﹤0.01% |
14,200
-17,100
| -55% | -$241K |
|
11084
CALL
Adecoagro
AGRO
$1.36B
| $179K | ﹤0.01% |
+22,600
| New | +$177K |
|
11085
PUT
Aemetis
AMTX
$124M
| $179K | ﹤0.01% |
128,900
+50,600
| +65% | +$102K |
|
11086
CALL
Ring Energy
REI
$339M
| $179K | ﹤0.01% |
205,700
-144,800
| -41% | -$138K |
|
11087
Valens Semiconductor
VLN
$188M
| $178K | ﹤0.01% |
125,667
-125,039
| -50% | -$206K |
|
11088
PLAYSTUDIOS Inc
MYPS
$90.1M
| $178K | ﹤0.01% |
273,582
-35,832
| -12% | -$27.9K |
|
|
CRMG
11089
PUT
Leverage Shares 2X Long CRM Daily ETF
CRMG
$57M
| $178K | ﹤0.01% |
13,000
-3,700
| -22% | -$45.8K |
|
11090
PUT
Bain Capital Specialty
BCSF
$850M
| $178K | ﹤0.01% |
+12,800
| New | +$179K |
|
11091
PUT
Nu Skin
NUS
$267M
| $178K | ﹤0.01% |
18,500
-21,000
| -53% | -$217K |
|
11092
CALL
Allot
ALLT
$383M
| $178K | ﹤0.01% |
18,100
-45,800
| -72% | -$439K |
|
11093
CALL
Savara
SVRA
$1.19B
| $178K | ﹤0.01% |
+29,500
| New | +$144K |
|
|
PTRN
11094
CALL
Pattern Group Inc
PTRN
$3.91B
| $178K | ﹤0.01% |
+15,400
| New | +$224K |
|
|
TWO
11095
Two Harbors Investment
TWO
$1.27B
| $178K | ﹤0.01% |
16,919
-371,311
| -96% | -$3.71M |
|
11096
Titan Machinery
TITN
$445M
| $178K | ﹤0.01% |
+11,804
| New | +$190K |
|
11097
PUT
Vanda Pharmaceuticals
VNDA
$302M
| $177K | ﹤0.01% |
20,100
-5,800
| -22% | -$31.9K |
|
11098
China Automotive Systems
CAAS
$133M
| $177K | ﹤0.01% |
41,531
-3,630
| -8% | -$15.5K |
|
|
YETH
11099
CALL
Roundhill Ether Covered Call Strategy ETF
YETH
$60.8M
| $177K | ﹤0.01% |
+10,100
| New | +$207K |
|
11100
PUT
Annexon
ANNX
$886M
| $177K | ﹤0.01% |
35,200
+18,800
| +115% | +$71.9K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.